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Introduction 
Aesop, in the Sixth century B.C., in his fable "The Four 
Oxen and the Lion", described a prowling lion in a field 
containing four oxen. Whenever the lion attacked, they 
turned their tails to one another, and he always faced the 
horns of one of them. But they quarreled, each went off to a 
separate corner of the field, and the lion then attacked them 
one by one and ate them. The fable's motto was "United we 
stand, and divided we fall". 
The phrase has been used repeatedly in politics, during the 
founding of the US, and again to unite India during its 
struggle for independence. The basic idea is that, unless 
people are united and one people, it is easy to destroy them; 
thus, the maxim: 'Divide and conquer'. 
I would like to argue that, until recently, this maxim, 'divide 
and conquer', has been the paradigm of the nutrition com-
munity's approach to micronutrient deficiencies, but it has 
not been an effective one. 
Let's look at recent progress. In the early 1990s, the 
International Conference for Nutrition and the World Fit 
for Children boldly proclaimed new goals to reduce malnu-
trition in young children. They included: 
• The sustained elimination of vitamin A and iodine defi-
ciencies by 2005; 
• Reduction by one-third in the prevalence of anemia, 
including iron deficiency, by 2010; 
• Accelerated progress toward reduction of other micro-
nutrient deficiencies. 
Fifteen years later, where are we? 
• Vitamin A deficiency weakens the immune system and 
contributes to the death of 1 million children each 
year; 
• Iodine deficiency in pregnancy results in 18 million 
babies a year born mentally impaired; 
• Maternal folate deficiency causes a quarter of a million 
severe birth defects each year; 
• Zinc deficiency contributes to 5% of all child deaths; 
• Maternal iron deficiency anemia results in more than 
60,000 women a year dying during pregnancy and 
childbirth. It impairs the mental development of 40% 
of the developing world's children. 
Micronutrient deficiencies also have profound economic 
costs. In 2006, the World Bank reported, "...vitamin and 
mineral deficiencies impose high economic costs on virtu-
ally every developing nation." According to economist Sue 
Horton, "micronutrient deficiencies alone cost India US$2.5 
billion annually and the productivity losses from stunting, 
iodine deficiency, and iron deficiency are responsible for a 
total loss of 2.95% of GDP." 
At the 2002 UN General Assembly Special Session on 
Children, it was clear we were falling far short of the ambi-
tious goals of the early 1990s: for iodine and vitamin A defi-
ciencies, we were perhaps a little more than halfway, and 
there had been essentially no progress against anemia. 
The traditional paradigm of the nutrition community's 
approach to micronutrient deficiencies, to 'divide and con-
quer', has hampered progress at three levels: 
• Each of the individual micronutrients -vitamin A, iron, 
iodine and zinc- were cornered by an 'expert' group. 
IVACG took vitamin A, INACG iron, ICCIDD iodine, 
IZINCG zinc, and they each went zealously to work. 
There was little dialogue between them and poten-
tial interactions or combined approaches were largely 
ignored. 
• Similarly, each of the different strategies —fortifica-
tion, supplementation, and dietary diversification— 
had their different proponents; they have rarely been 
integrated into combined programs. Consider iron 
deficiency anemia. From 1993-96, led by Unicef, 122 
countries distributed nearly 3 billion iron supplements 
to pregnant women; 1 billion more iron-folate tablets 
were handed out in 1999-2000. What was the impact? 
The prevalence of anemia in pregnancy in South Asia 
and sub-Saharan Africa is still at least 50%. It has since 
become clear that reducing anemia will only be achieved 
through an integrated approach of targeted supplemen-
tation, food fortification and infection control. 
• And finally, the different organizations interested in 
fighting micronutrient deficiencies 'did their own 
thing'. Industry looked for new markets and profits, 
W H O promulgated policy, UNICEF and the other 
NGOs competed for donor money for implementation, 
while academia did research and, naturally, stayed above 
it all. 
Looking back, how could we expect solid progress from such 
a fragmented approach? 
Thus, I would like to turn Aesop's maxim on its head and 
suggest a new maxim of "Divided they stand, united they 
fall" more appropriately describes a successful future strat-
egy for controlling micronutrient deficiencies, and perhaps 
holds the key to eliminating them. 
This concept will help shape research programs in this new 
Professorship, and thus, the title of my lecture today. 
This new maxim should be applied on 3 levels to control 
micronutrient deficiencies: 
• First, at the physiological level; synergistic interactions 
suggest approaches that target individual micronutrient 
deficiencies are much less efficacious than combined 
approaches; 
• Second, integrated programs of supplementation, for-
tification and dietary improvement may succeed where 
each alone will only be partially effective; 
• And finally, innovative partnerships within academia, 
and at the organizational level, emphasizing public-pri-
vate collaboration, are a key to success. 
Let's look at each of these in more detail. 
Combined micronutrient approaches work better 
First, at the physiologic level. Attacking each micronutrient 
deficiency individually is much less effective than attacking 
them simultaneously. Why? Because single micronutrient 
deficiencies don't occur in isolation: overlapping deficien-
cies of iron, vitamin A and iodine, and perhaps zinc, affect 
more than 50% of children and young women in develop-
ing countries. And deficiencies of one micronutrient will 
interfere with efforts to control the others. 
These interactions are fascinating in that they can occur 
deep inside cell metabolism, at the level of the gene and/or 
enzyme. 
My eminent predecessor at Wageningen, Clive West, showed 
adequate vitamin A is critical for optimal iron metabolism 
and utilization, and that the response to iron supplemen-
tation is blunted by vitamin A deficiency. Building on his 
work, we have recently shown this is due to vitamin A status 
modulating renal production of erythropoietin, an impor-
tant stimulus to production of new red blood cells. 
As another example, iodized salt effectively controls goiter 
and iodine deficiency most of the time, but not always. The 
effectiveness of iodine prophylaxis is dependent on the vita-
min A and iron status of the target population. 
Vitamin A and iodine 
Vitamin A deficiency has multiple effects on the pituitary-thy-
roid axis, both in the periphery and in the brain. Studies by 
Morley and co-workers 3 decades ago showed vitamin A defi-
ciency in rats increases thyroid hormone levels and thyroid size, 
and, conversely, large doses of vitamin A decrease them. 
But the mechanism of this effect was not discovered until the 
mid 1990s. Normal control of TSH secretion by the pitui-
tary involves feedback from circulating thyroid hormone. 
Surprisingly, vitamin A status also modulates TSH secretion 
by the pituitary. It turns out that both the thyroid hormone-
activated thyroid receptor and the retinoic acid-activated 
retinoid X receptor suppress transcription of the pituitary 
TSHß gene by occupying half-sites on the promoter DNA 
of the gene. Therefore, high doses of vitamin A and/or high 
circulating thyroid hormone levels will decrease transcription 
of the pituitary TSHß gene and TSH secretion, and thereby 
reduce thyroid stimulation. Conversely, vitamin A deficiency 
and/or low levels of circulating thyroid hormone will increase 
circulating TSH level, stimulating the thyroid gland. 
In Zürich, Biebinger and co-workers recently investigated 
the effects of concurrent vitamin A and iodine deficiencies 
on the thyroid-pituitary axis in rats. Compared to iodine 
deficiency alone, expression of TSHß mRNA was much 
higher in the combined deficient group, and they had more 
goiter. These data indicate concurrent iodine deficiency and 
vitamin A deficiency produce more severe primary hypothy-
roidism than iodine deficiency alone, through effects at the 
level of the pituitary TSH gene. 
The adverse effects of iodine deficiency are due to hypothy-
roidism. Could a goitrous child's vitamin A status influence 
his/her risk for hypothyroidism? 
To answer this, we studied children with concurrent iodine 
and vitamin A deficiencies in the mountains of northern 
Morocco. Increasing severity of vitamin A deficiency was 
a predictor of greater thyroid volume and higher concen-
trations of TSH; in children with vitamin A deficiency, the 
odds ratio for goiter was 6.5. But at the same time, it was 
a strong predictor of higher concentrations of thyroid hor-
mone; the odds ratio for hypothyroidism in vitamin A defi-
ciency was only 0.06. 
The children were then given iodized salt, together with 
either vitamin A supplementation or placebo. The goiter 
rate was sharply decreased in the vitamin A group, compared 
to placebo. 
In a follow-up study in the Limpopo region of South Africa, 
in children with both vitamin A deficiency and iodine 
deficiency, a randomized, 2x2 intervention trial was done. 
Children received supplements of iodine or vitamin A alone, 
both or neither. There was a clear effect of vitamin A sup-
plementation, independent of iodine supplementation, on 
reducing TSH, thyroid volume and goiter. 
Thus, vitamin A supplementation in goitrous children 
improves their response to iodized salt. It decreases excess 
TSH stimulation of the thyroid and reduces risk for goiter 
and its sequelae. These findings are likely mediated through 
the pituitary retinoid receptor and TSHß gene expression. 
Iron and iodine 
There is a similar interaction between iron and iodine. It has 
long been recognized that thyroid hormone metabolism is 
abnormal in iron deficiency anemia. In the 1990s, John Beard's 
group at Penn State reported that iron supplementation of 
anemic women increased circulating thyroid hormone. 
But the mechanism by which iron deficiency impairs thyroid 
metabolism was unclear. Recently, we uncovered a mecha-
nism: iron deficiency reduces activity of an iron-dependent 
enzyme in the thyroid, thyroid peroxidase (TPO). TPO cata-
lyzes the two initial steps of thyroid hormone synthesis, and 
without enough iron, TPO cannot form thyroid hormone. 
The effect of iron deficiency anemia in reducing TPO activity 
was demonstrated in weanling rats that were fed progressively 
more iron-deficient diets. TPO activity was reduced by 33-
56% in iron deficiency, and the rats became hypothyroid. 
If iron deficiency can lower TPO activity and thereby impair 
thyroid metabolism, could iron deficiency block a child's 
ability to use the iodine in iodized salt? 
This question prompted us to begin a series of studies in 
children in an area of endemic goiter in the mountains of 
western Côte d'Ivoire. 
In the first study, iodine deficient children were divided into two 
groups: the first group consisted of goitrous children without 
anemia, and the second of goitrous children with iron deficiency 
anemia. Each child received a large dose of iodine. Followed for 
6 months, TSH values were lower, and thyroid hormone levels 
higher, in nonanemic compared to anemic children. There was 
a sharp difference in goiter prevalence during follow-up, when 
goiter rates were 64% in the anemic children but only 12% in 
the nonanemic children. Thus, iodine improved both anatomic 
(thyroid size) and biochemical (TSH, thyroxine) measures of 
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thyroid function in the nonanemic children compared to the 
children with iron deficiency anemia. 
Then, each iron deficient anemic child received treatment 
with iron. Goiter prevalence in this group, which had pla-
teaued at 62-64% after receiving iodine, was reduced after 
iron supplementation to 20%. 
The final study was a controlled trial of iron supplemen-
tation in goitrous children with iron deficiency who were 
receiving iodized salt. This was a double-blind intervention 
study. One group received oral iron, and the second group 
received placebo. After 5 months, thyroid size decreased 2-
fold and the goiter rate was significantly lower in the iron 
supplemented group. 
These studies have clarified why iodized salt will work less 
well in areas where vitamin A and iron deficiencies are com-
mon: both interfere with iodine metabolism. For vitamin 
A, the interaction occurs at a pituitary gene; for iron, at a 
thyroid enzyme. 
This argues strongly for a combined approach, or 'united 
they fall': when children are deficient in several micronutri-
ents at one time, concurrent micronutrient repletion may be 
necessary for optimal effect. Moreover, addition of multi-
ple micronutrients to a single foodstuff might cost less than 
separate fortification programs. 
Triple-fortified salt 
Because both iron and vitamin A deficiencies reduce the effi-
cacy of iodized salt, the co-fortification of iodized salt with 
11 
iron and vitamin A could be beneficial, not only to combat 
anemia and vitamin A deficiency, but also to improve the 
efficacy of iodine in the salt. Salt is often the only fortifica-
tion vehicle available in rural Africa, because in poor regions 
of subsistence farming, salt is one of very few regularly pur-
chased food items. 
But combining multiple micronutrients together in a single 
food vehicle, particularly salt, creates challenges. Ferrous iron 
is well absorbed but colors low-grade salt yellow to brown. 
So we turned to ferric pyrophosphate, an iron compound 
with a white color that produces negligible color change 
when added to salt, and we ground it down to micron size 
to increase its absorption. Another challenge is that, in the 
presence of ferrous iron and moisture, losses of iodine and 
vitamin A from a fortified salt are high. Encapsulation could 
form a barrier between iron, iodine and vitamin A, and 
might overcome these challenges. 
Therefore, to develop a triple fortified salt, we turned to food 
engineering, and used a novel spray-cooling process to micro-
encapsulate iron, iodine and vitamin A in hydrogenated oil 
in a single processing step. A heated fat suspension is atom-
ized with specifically designed 2-phase nozzles into partially 
evaporated liquid nitrogen. Smooth, tight, microspheres are 
formed that are 40% substrate and 60% capsule. 
After testing the stability and acceptability of the triple forti-
fied salt, we measured its efficacy in a randomized double-
blind trial in Moroccan children. It was given to households 
for 10 months. There was a significant decrease in the preva-
lence of iron deficiency anemia and vitamin A deficiency 
in the children receiving the triple fortified salt compared 
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to iodized salt. Moreover, the iodine was more efficacious: 
goiter prevalence and the number of hypothyroid children 
were sharply lower in group receiving the triple fortified 
salt. This study showed for the first time that even low-
grade African salt can be successfully triple-fortified with 
microcapsules. 
Within the new Professorship, in collaboration with food 
scientists of this University, we plan to develop innovative 
strategies in food technology to overcome the challenges to 
multiple fortification. Microencapsulation may offer new 
opportunities for the multiple fortification of other vehicles, 
e.g. flours (this is currently being tested in wheat flour in 
Kuwait) and extruded rice. 
Integrating strategies to control micronutrient 
deficiencies 
The limitations of current strategies 
Moving from micronutrient interactions to the strategy 
level, our new maxim "divided they stand, united they fall" 
should guide the development of integrated programs. 
For decades the three main strategies to control micronutri-
ent deficiencies have been: 
• Dietary diversification, often based on consumer educa-
tion, and sometimes agriculture; 
• Food fortification; 
• Supplementation. 
But a clear lesson drawn from the experience of the last two 
decades is that although each of these can contribute to the 
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control of micronutrient deficiencies, none can do the job 
alone. These individual strategies are limited in that they 
may provide only a fraction of the micronutrient required, 
work only for a specific population group, operate on a dif-
ferent time scale, or be the responsibility of a different gov-
ernment agency. 
Most would agree dietary diversification is the best long-
term, sustainable strategy. But progress has been slow, and 
in some developing countries with deteriorating economies, 
we need to be realistic and accept that food diversification 
is unlikely to significantly reduce micronutrient deficiencies 
in the near future. Moreover, long-term economic develop-
ment and poverty reduction cannot be relied upon to elimi-
nate micronutrient deficiencies. The children of many high-
income families in the industrialized countries would lack 
essential micronutrients if infant foods, salt and cereals were 
not fortified. 
Considering fortification, its success depends on finding 
a food that is widely eaten and yet passes through com-
mercial processing where the micronutrient can be added. 
Moreover, the food must be consumed regularly and in 
adequate amounts by those most vulnerable to the defi-
ciency. Universal fortification often cannot provide adequate 
amounts to children below two years, a group vulnerable to 
permanent damage from micronutrient deficiencies. 
Supplementation can be effective, but is likely sustainable 
only when given in huge doses as depot forms at intervals 
of 4 to 12 months, as is done with vitamin A and iodinated 
poppy seed oil. Although clearly effective at reducing end-
points like mortality or cretinism, the overall safety profile 
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of these large doses, particularly in pregnancy and early 
infancy, has not been rigorously tested. The logistics of daily 
or weekly supplementation are daunting, and, particularly 
for iron, compliance is often poor. 
Separate application of these strategies in the past has led 
to disjointed, piecemeal efforts to control micronutrient 
deficiencies. Future success will depend on deploying not 
just one solution, but different combinations in a well-knit 
plan. A good example of an integrated approach within this 
new Chair is the TELFUN project that links the Division of 
Human Nutrition with plant scientists, food scientists, and 
social scientists to increase food sovereignty and nutritional 
status in Ecuador, India and Ghana. 
Another reason for the slow progress against the micronu-
trient deficiencies has been too little innovation. Certainly 
dietary diversification, fortification, and supplementation 
remain important, but they often feel 'tired-out'. In any 
scientific field, innovation is critical to achieving real break-
throughs. In order to add innovation, we need to unite with 
new scientific partners. Two examples are alliances with 
plant sciences and genetics for biofortification, and with 
particle sciences for nanotechnology. 
The cautious promise of biofortification 
Long-term, sustainable control of the micronutrient defi-
ciencies will not happen unless we include agricultural 
approaches. Staple crops can be enriched ('biofortified') with 
micronutrients using plant breeding and/or transgenic strat-
egies that exploit enrichment traits within their genomes. 
This must be done without adversely affecting crop produc-
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tivity. The bio-fortification of maize, millet, sorghum, yams, 
beans, cassava, rice and sweet potatoes is a potentially pow-
erful weapon against micronutrient deficiencies. 
But increasing the amount of a micronutrient in a food may 
not be enough. For trace elements like iron and zinc, the 
nutrients must also be bioavailable. 
Take rice as an example. Worldwide, rice feeds more than 
half the human population, most of who live in developing 
countries. Rice contains small amounts of iron in the aleu-
rone layer of the seeds, which is polished away. Consequently, 
iron deficiencies are widespread in monotonously rice-eat-
ing populations. 
The variation in the iron content among cultivars of rice 
suggests selective breeding may be able to increase iron con-
tent. But although there is a range of iron content in rice of 
7-23 mg/kg, most of this iron is removed during the milling 
process. Thus, it may be difficult to increase the absolute 
iron level of milled rice through plant breeding. This prob-
lem was evident when the efficacy of a rice cultivar high in 
iron was tested in a feeding trial in The Philippines. Because 
the 'high-iron' rice added only an extra =1.5 mg iron per day 
to the diet, there was no clear improvement in iron status. 
Iron absorption from cereals and legumes (many have high 
native iron content) is low because of they have high lev-
els of phytate and polyphenols, substances that inhibit iron 
absorption. In order to achieve real breakthroughs in bio-
fortification, it is likely going to be necessary to decrease the 
amount of these inhibitory substances, or increase the level 
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of enhancing substances (e.g. ascorbic acid, sulfur-contain-
ing amino acids). 
Genotypes of maize, barley, and rice have been identified 
that are low-phytic-acid mutants, with phytic acid phospho-
rus content reduced by up to two thirds. However, it may 
be necessary to decrease phytic acid by >90% to usefully 
increase iron absorption from the monotonous cereal-based 
diets found in many developing countries. 
Because of these limitations, genetic engineering may prove 
to be the most effective way to provide a useful amount of 
absorbable iron in plant foods. Working with the same plant 
scientists who created 'golden rice' at the ETH Zürich, a 
combined approach was used to modify three genes in rice 
in order to increase the amount of bioavailable iron. 
First, a gene for the iron storage protein ferritin from the 
common field bean (Phaseolus vulgaris) was expressed 
under the control of an endosperm specific promoter in 
rice, increasing the iron content in the endosperm by 
about 3-fold. Second, a phytase (an enzyme that degrades 
phytate, a strong inhibitor of iron absorption) from a fungus 
(Aspergillus fumigatus) was expressed in the rice. Finally, the 
gene for a cysteine-rich metallothionine was over-expressed 
in the rice, increasing the cysteine content in the soluble 
fraction of the seed proteins is by 7-fold. Sulfur-containing 
amino acids like cysteine may improve iron absorption. 
Thus, not only was the iron content of the endosperm 
increased, but the level of both an enhancer and inhibitor were 
adjusted to maximize absorption. This may be the method 
most likely to yield benefits in biofortification with iron. 
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These preliminary studies suggest iron content can be 
increased in staple foods by plant breeding and, even more 
promising, by genetic engineering. The challenge is now to 
show that iron can be increased to nutritionally-useful levels 
and that the additional iron is bioavailable. To do this, the 
Chair will work closely with Harvest Plus, a global alliance 
formed to biofortify staple food crops. 
Biofortification is an exciting new tool that may be able 
to reach the most vulnerable, rural poor. Within this new 
Chair, its ability to fight micronutrient deficiencies will be 
fully explored. 
Nanotecbnolagy may enhance trace element delivery 
The central challenge in iron fortification is that water-solu-
ble, highly bioavailable iron compounds cause adverse sen-
sory changes in foods, while poorly soluble iron compounds, 
although more stable in foods, are poorly absorbed. 
To overcome this, we have recently turned to nanotech-
nology. Reducing the particle size of poorly absorbed iron 
compounds to submicron size is promising because it greatly 
increases their bioavailability, and, thus, their nutritional 
value. 
In medicine and pharmaceutics, nanotechnology is increas-
ingly applied to enhance the absorption of drugs and vaccines. 
Also, nanosized silicon- and titanium dioxides are currendy 
used in food and drink products; for example, nano-sized sili-
con dioxide is added to powders increase flowability. 
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However, the potential of nanotechnology to enhance nutri-
tional value is largely unexplored. Recently, with the Particle 
Technology Laboratory in Zürich, we developed the first iron 
nanoparticles for nutritional applications. We synthesized 
amorphous ferric phosphate nanopowders using flame spray 
pyrolysis. Regular-sized ferric phosphate is a poorly soluble 
iron compound of little nutritional value due to its low bio-
availability. Flame spray pyrolysis can produce tailor-made 
particles with high surface area and well-defined chemical 
composition. It is an established, scalable technology that 
may prove cost-competitive for production of nanoparticles 
for nutritional supplementation and/or food fortification. 
These ferric phosphate nanoparticles had a mean particle size 
of 10 nm— 10,000 of them would fit across the diameter 
of a human hair. They were compared to the 'gold standard' 
iron compound, ferrous sulfate, in vitro and in animal stud-
ies. Ferrous sulfate, although very well-absorbed, usually 
colors foods brown. The results showed that the nanosized 
ferric phosphate had remarkably high solubility and bio-
availability in rats, equal to that of ferrous sulfate. 
This novel approach could lead to the development of the 
next generation of trace element compounds for human 
nutrition. Poorly absorbed compounds with superior sensory 
qualities, when reduced to nanoscale, may become useful for 
human nutrition, because particle size reduction increases 
their absorption while retaining their sensory inertness. 
Considering the clear advantage of tackling micronutrient 
deficiencies in a combined approach, in Zürich we are now 
producing atomically-mixed iron and zinc nanoparticles. 
Overlapping iron and zinc deficiencies are common in the 
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developing world, and co-fortification could be beneficial, 
particularly since high amounts of iron inhibit zinc absorp-
tion when given as supplements but may not when given 
with food. 
We are also investigating packaging nanosized iron and zinc 
in folate-containing capsules for folate-receptor targeted 
delivery in the duodenum. Folic acid is a B-vitamin essential 
for building blood cells, and its deficiency, along with iron 
deficiency, is a common cause of anemia. It is often supple-
mented along with iron to control anemia in children and 
pregnant women. The inclusion of folates in liposomes sur-
rounding nanoparticles may not only deliver folic acid but 
also enhance iron and zinc absorption. 
These examples suggest uniting traditional strategies of sup-
plementation, fortification and diversification with innova-
tive new technologies like genetic engineering and nano-
science may provide the breakthroughs we need to finally 
control the micronutrient deficiencies. 
Uniting in public-private partnerships 
Control of micronutrient deficiencies has been tradition-
ally perceived as a problem to be dealt with by health care 
workers treating those with clinical signs of deficiency. But 
in the last 10 years, it has become clear that new alliances 
are needed to achieve what the public health sector alone 
cannot. 
Since the mid 1990s, a growing international dialogue on 
micronutrient malnutrition has led to new coalitions that 
include: 
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• Governments and their citizens; 
• The commercial sector and its market; 
• Academia in developing and industrialized countries; 
• International agencies, including UN and non-govern-
ment organizations. 
These alliances follow the new maxim, "divided they stand, 
united they fall", in their approach to micronutrient deficien-
cies. Examples of global public-private coalitions include the 
Global Alliance for Improved Nutrition (GAIN), and the 
Flour Fortification Initiative, and the Global Network for 
the Sustained Elimination of Iodine Deficiency. 
Even the traditional strict division of the micronutrients by 
expert advisory groups may be changing. In April 2007, the 
new Micronutrient Forum brought them together under one 
roof, and for the first time a single major meeting specifically 
addressed the major micronutrient deficiencies - vitamin A, 
iron, zinc, folate and iodine. 
This Professorship 
The movement toward alliances in nutrition leads logically 
to why the endowment of this Chair in Micronutrients 
and International Health by Unilever is so prescient, and 
so important. Until now, fortification, particularly to con-
trol iron deficiency, has been less successful than hoped 
for. Effective public-private partnerships could change this, 
as the public sector (with the mandate to improve public 
health) and the private sector (with the expertise in food 
development and marketing) work together. 
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One of the main goals in this new Chair will be to clearly 
define the extent and impact of the micronutrient deficien-
cies, develop innovative technology and rigorously evaluate 
new fortification strategies, including bioavailability and 
efficacy. But it is only the private sector —such as Unilever 
and their Regional Nutrition and Health teams in the devel-
oping world— that can take the next step to develop, dis-
tribute and market fortified foods to whole populations. 
This Chair reflects Unilever's commitment to help reduce 
child mortality and malnutrition worldwide. This com-
mitment is also evident in Unilever's global partnerships 
with the World Food Program, GAIN and UNICEF that 
focus on food fortification, child nutrition, and school 
feeding programs. Within the Chair, Unilever has funded 
a Research Program focusing on mental development of 
children, including funding for three PhD and six MSc stu-
dents. Three MSc students, from Kenya, Thailand and the 
Philippines, will begin their studies in September. 
Under the exemplary leadership of Jo Hautvast, Clive 
West and Frans Kok, the Division of Human Nutrition at 
Wageningen has become a global leader in international 
nutrition. Through its longstanding collaborations with 
institutions in developing countries and its sandwich PhD 
fellowships, the Division has been hugely influential in 
capacity building, particularly in Asia and Africa. Currently 
20 international PhD students are ongoing, and yearly 
about 10 international students are enrolled in the MSc 
programme Nutrition and Health. Strong research lines 
have been developed on micronutrient deficiencies, mainly 
deficiencies of vitamin A, iodine, iron and zinc. The efficacy 
trial of NaFeEDTA-fortified whole maize flour in Kenya 
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published last month in the Lancet by Pauline Andang'o 
and co-workers is a fine example of a Wageningen sandwich 
PhD program producing groundbreaking research in the 
field of micronutrients. 
Within the new Chair, I plan to build on these strengths 
of the Division, particular in the field of metabolic aspects 
of micronutrient malnutrition. To do this, we will develop 
partnerships with other groups at Wageningen, as well as 
at the ETH Zürich, to exploit the latest technology in sta-
ble isotopes, biofortification, nanoscience and food process 
engineering. The expertise of the Human Nutrition group 
in Zürich in stable isotopes of iron and zinc complement 
our Division's expertise in organic mass spectroscopy. A new 
project examining the interactions of heme iron and folate 
absorption at a shared duodenal transporter will draw on the 
stable isotope expertise of both groups. 
One focus of the Chair will be micronutrition and mental 
development in children. Although controlled trials have 
suggested benefits of iron, iodine and perhaps zinc on cogni-
tion, the mechanism(s) remain largely unknown. Available 
clinical tests to assess cognition are limited by their high 
variability. The rapid advance of electrodiagnostic studies 
and functional brain imaging techniques, such as MRI and 
FDG-positron emission tomography, may allow us to more 
objectively measure and characterize cognitive changes due 
to malnutrition. Also, use of gene arrays, proteomics, and 
metabolomics will point to the cellular mechanisms that 
underlie a clinical response to nutritional interventions. 
These techniques may allow us to identify the adverse effects 
of marginal micronutrient deficiencies not only in child-
hood, but also in pregnancy. In September, two new PhD 
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students within the Chair, one from India and one from 
Thailand, will begin to study the adverse affects of maternal 
iodine deficiency on thyroid function and neurocognitive 
development of the offspring, using these approaches. 
At Wageningen, the Chair plans to work closely with the 
other groups in the Division of Human Nutrition. At the 
molecular level, with the group of Michael Müller, as well 
as the Cell Biology and Immunology Group, new func-
tional tests using peripheral macrophages may elucidate 
the metabolic effects of malnutrition on immune function 
and inflammatory cytokines. This could provide important 
insight into the critical link between micronutrient deficien-
cies and infections common in developing countries, such as 
malaria, tuberculosis and HIV/AIDS. 
At the population level, an area of shared research will be 
the effects of the so-called 'double burden' of malnutrition 
of both obesity and micronutrient deficiencies in transition 
and developing countries, and their interactive contribution 
to diabetes, chronic inflammation, and cardiovascular dis-
ease. Another shared interest is selenium deficiency, both its 
role in induction of cancer as studied by Pieter van 't Veer 
and his group, and its potential role in increasing the burden 
of infectious diseases in developing countries. Collaboration 
with Renger Witkamp will help bring the lessons learned 
from nanoparticle use in pharmaceuticals to food applica-
tions. We will turn to Kees de Graaf to help evaluate poten-
tial sensory changes in foods induced by biofortification or 
nanotechnology. Finally, the expertise of Lisette de Groots 
group on nutrition and cognitive function in the elderly is 
complementary to our planned studies in children. 
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In teaching, a goal of the Chair will be to consolidate the 
lectures on micronutrients currently scattered throughout 
the BSc and MSc programs in Nutrition and Health, and 
develop one or more specific MSc-courses on micronutri-
ent nutrition in developing countries. Also, in collaboration 
with Wageningen graduate schools such as VLAG, we plan 
to implement an intensive post-graduate course on micro-
nutrient malnutrition, taught by a high-profile, interna-
tional faculty. 
Thanks 
Many people were involved in my medical and scientific 
training at the Universities of Vanderbilt and California at 
Berkeley, as well as at the ETH in Zürich. The late Philip 
Felts, my mentor at Vanderbilt, assured me that as valedic-
torian of my class I was not obliged to be a surgeon, and 
encouraged me to go into endocrinology. At Berkeley, Janet 
King taught me respect for nutritional science, and Norman 
Kretchmer introduced me to international nutrition on an 
unforgettable trip to study diabetes in aboriginal children in 
the Australian outback. 
In Zürich, I have had the extreme good fortune to have 
worked alongside Richard Hurrell for the past 10 years. 
His scholarship and integrity have made a deep impression. 
Working with Emorn Wasantwisut in Bangkok, Pieter Jooste 
in Cape Town and Sumithra Muthayya in Bangalore has 
been an enormous pleasure. I have also had a steady stream 
of unusually talented and amiable PhD students working in 
developing countries. 
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With respect to my Professorship at Wageningen, I would 
like to express my appreciation to Unilever for their gener-
osity in initiating this Chair, in particular, to Jan Weststrate 
and Marti van Liere. For allowing me to take up this posi-
tion in Wageningen, I would like to thank the Council of 
Wageningen University and Research Center represented by 
the Rector of the University (Prof. Martin Kropfï) and the 
Chair of the Division of Human Nutrition (Frans Kok). I 
look forward to working with Inge Brouwer, Alida Melse and 
Saskia Osendarp, and am entirely counting on their hard-
working day-to-day leadership, considering I will only be at 
Wageningen the equivalent of one day a week! I would also 
like to thank Gea Brussen and Lous Duym, in the Division 
of Human Nutrition, for arranging this event today. 
Finally, I would like to thank my family for bringing me so 
far. My young children, Henry and Sophie, are very proud 
of their father and would have been more than happy to 
have skipped two days of Swiss school to be here. And Tanja, 
for your sense of humor, for your ability to somehow bal-
ance running both a company and a family, and for always 
putting things back into the right perspective. 
Conclusions 
In conclusion, malnutrition remains the world's most serious 
health problem and the single biggest contributor to child 
mortality. With more than a third of the developing worlds 
population suffering from micronutrient deficiencies, unless 
policies change, these deficiencies may prevent many coun-
tries from achieving the Millennium Development Goals 
—in Sub-Saharan Africa, where malnutrition is increasing, 
and in South Asia, where it is improving only slowly. 
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The 2004 Copenhagen Consensus of eminent economists 
(including several Nobel laureates) concluded that the 
returns of investing in micronutrient programs are second 
only to fighting HIV/AIDS among a long list of ways to 
meet the worlds development challenges. The Consensus 
concluded, ".. .no other technology offers as large an oppor-
tunity to improve lives at such low cost and in such a short 
time." 
Divided, micronutrient deficiencies may stand, but united, 
integrated strategies targeting multiple deficiencies driven 
by public-private partnerships will, in the end, cause them 
to finally fall. We need to seize this opportunity to ensure 
that, worldwide, the next generation of children grow up 
and develop to their full mental and physical potential. 
Thank you. 
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